S
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
Price:
28.31
CNY
1.8%
Market Closed
Market Cap:
¥1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
|
CN |
|
Future Data Group Ltd
HKEX:8229
|
KR |
|
T
|
Tefron Ltd
TASE:TFRLF
|
IL |
Multiples-Based Value
The Multiples-Based Value of one Shanghai Rightongene Biotechnology Co Ltd stock under the Base Case scenario is 25.31 CNY. Compared to the current market price of 28.31 CNY, Shanghai Rightongene Biotechnology Co Ltd is Overvalued by 11%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
25.31
CNY
Overvaluation 11%
S
Multiples Across Competitors
Competitors Multiples
Shanghai Rightongene Biotechnology Co Ltd Competitors
Shanghai Rightongene Biotechnology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
|
1.6B CNY | 7.5 | -74 | -39.3 | -39.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD | 6.3 | 91.5 | 15.1 | 21 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD | 111.3 | -1 738.3 | 16 147.7 | -1 823.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD | 5.8 | 19.9 | 12.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.7 | 18.1 | 13.5 | 15.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD | 3.1 | 34.8 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
